ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP II System for Cord Blood…
ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics and a market leader in automated cellular processing, today announced that it has received Health Canada approval of…
Read More...
Read More...
